Reach Us +1-217-403-9671
Regulatory Affairs For Healthcare Products | 7485
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Regulatory affairs for healthcare products

2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

Amudha Krishnamurthy

Accepted Abstracts: Pharmaceut Reg Affairs

DOI: 10.4172/2167-7689.S1.008

Regulatory Affairs has always been considered as a Drug registration department in Indian Pharmaceutical industry. When Drug Registration and Marketing approvals are essential day to day activities of a regulatory professional, there is lot more aspects bound to it beyond product registration. In a true scenario, Regulatory Affairs is a horizontal that cut across the Pharmaceutical Value chain right from Drug discovery, Drug Development, Manufacturing, Sales and Marketing and Post Marketing. In all of these phases there are number of compliance parameters to be met in order to pass the stringent regulatory scrutiny. Regulatory Compliance plays an integral role in Regulatory Affairs. It is a common belief that, when the product complies with its specification then quality is achieved. Testing the final product cannot assure the quality unless and otherwise it is built into the product itself. The concept of Quality by Design (QbD) helps in building the right product with a thorough understanding of the product and process by which it is developed. QbD applies equally to the software used in the Pharmaceutical Industry. Understanding and interpreting these regulations has always been a challenge in Pharma because Regulations like US FDA or UKMHRA would only provide the guidance document on its interested topics, the how aspect is left to the Pharmaceutical Company. Complying with these regulations is purely based on a company?s internal policies and Procedures. Despite these regulations exist for so many years now, even today there are so many non- conformances and FDA 483s. What is the challenge? Why compliance is always considered as a painful exercise? What role does a Regulatory Affairs professional play in this entire process? Wait and watch my session for the answers.
Amudha Krishnamoorthy is a Life Sciences Quality and Regulatory Consultant having 15 years of Experience. She has served in Departments like Manufacturing, Quality Assurance and Regulatory Affairs in her Pharmaceutical Industry career and currently working as a Regulatory Consultant in IT Company. Her expertise includes GxP Compliance, Software Compliance and Regulatory Submissions. She is also a certified mentor for Life Sciences imparting domain knowledge to the IT folks.
Relevant Topics